Alprazolam ( DrugBank: Alprazolam )

2 diseases

ID	Disease name (Link within this page)	Number of trials
8	Huntington disease	1
75	Cushing disease	1

8. Huntington disease

Clinical trials : 229 / Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00975481 (ClinicalTrials.gov)	October 2009	10/9/2009	A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users	A Randomized, Double-Blind, Placebo- And Active-Controlled Single-Dose, Crossover Study To Evaluate The Abuse Potential Of Single Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users	Alzheimer's Disease;Huntington's Disease	Drug: dimebon;Drug: placebo;Drug: alprazolam	Pfizer	Medivation, Inc.	Completed	18 Years	55 Years	All	36	Phase 1	Canada

Clinical trials : 203 / Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT1021210011	10/06/2021	10/06/2021	A diagnosis of pseudo-Cushing's syndrome using dexamethason/CHR and Alprazolam	A diagnosis of pseudo-Cushing's syndrome using dexamethason/CRH and anxiolytic Alprazolam	Pseudo Cushing's Syndrome Glucocorticoid , Stress, dexamethasone suppression test;D003480	In patients suspected of having Cushing's syndrome or pseudo-Cushing's syndrome, we perform two loading tests, DEX/CRH and alprazolam tests, in order to confirm the differential ability of this test.	Asari Yuko	NULL	Recruiting	Not applicable	Not applicable	Both	100	Phase 2	Japan